Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

four seasons agribusiness pty ltd - methyl & ethyl esters of free fatty acids from canola oi - emulsifiable concentrate - methyl & ethyl esters of free fatty acids from canola oi acid-fatty active 704.0 g/l - adjuvant

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

titan ag pty ltd - methyl & ethyl esters of free fatty acids from canola oi - emulsifiable concentrate - methyl & ethyl esters of free fatty acids from canola oi acid-fatty active 704.0 g/l - adjuvant - herbicide additive | activator | penetrant | post emergent herbicide | spreading adjuvant | surfactant | wetting agent - tank mixing | additive | agricultural chemical | herbicide | minimise antagonism | spray tank

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

alphakem global pty ltd - methyl & ethyl esters of free fatty acids from canola oi - emulsifiable concentrate - methyl & ethyl esters of free fatty acids from canola oi acid-fatty active 704.0 g/l - adjuvant - herbicide additive | activator | penetrant | post emergent herbicide | spreading adjuvant | surfactant | wetting agent - tank mixing | additive | agricultural chemical | herbicide | minimise antagonism | spray tank

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dksh agrisolutions pty ltd - ethyl ester of c14 & c22 mixed fatty acids; potassium salt of castor oil fatty acids - emulsifiable concentrate - ethyl ester of c14 & c22 mixed fatty acids acid-fatty active 712.0 g/l; potassium salt of castor oil fatty acids mineral-potassium active 62.0 g/l - plant regulator - grape - gordo and waltham | grape - sultana | grapevine - promote fruit drying

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

pct holdings pty ltd - methyl & ethyl esters of free fatty acids from canola oi - emulsifiable concentrate - methyl & ethyl esters of free fatty acids from canola oi acid-fatty active 704.0 g/l - adjuvant

Israel - English - Ministry of Health

promedico ltd - iodine as ethyl esters of iodized fatty acids of poppy seed oil - solution for injection - iodine as ethyl esters of iodized fatty acids of poppy seed oil 480 mg/ml - non watersoluble x-ray contrast media - lymphography.- visualisation, localisation and vectorisation during trans-arterial chemo-embolisation (tace) of hepatocellular carcinoma, in adults.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

australian adjuvants pty ltd - methyl & ethyl esters of free fatty acids from canola oi; non-ionic surfactant - emulsifiable concentrate - methyl & ethyl esters of free fatty acids from canola oi acid-fatty active 704.0 g/l; non-ionic surfactant emulsifiers & surfactants-noni other 199.0 g/l - adjuvant

United States - English - NLM (National Library of Medicine)

par pharmaceutical inc. - omega-3-acid ethyl esters (unii: d87ygh4z0q) (omega-3 fatty acids - unii:71m78end5s) - omega-3-acid ethyl esters 900 mg - omega-3-acid ethyl esters capsules, usp are indicated as an adjunct to diet to reduce triglyceride (tg) levels in adult patients with severe (≥500 mg/dl) hypertriglyceridemia (htg). usage considerations: patients should be placed on an appropriate lipid-lowering diet before receiving omega-3-acid ethyl esters capsules, usp and should continue this diet during treatment with omega-3-acid ethyl esters capsules, usp. laboratory studies should be done to ascertain that the lipid levels are consistently abnormal before instituting  therapy with omega-3-acid ethyl esters. every attempt should be made to control serum lipids with appropriate diet, exercise, weight loss in obese patients, and control of any medical problems such as diabetes mellitus and hypothyroidism that are contributing to the lipid abnormalities. medications known to exacerbate hypertriglyceridemia (such as beta blockers, thiazides, estrogens) should be discontinued or changed if possible prior to consideration of triglyceride-lowering drug ther

United States - English - NLM (National Library of Medicine)

golden state medical supply, inc. - omega-3-acid ethyl esters (unii: d87ygh4z0q) (omega-3 fatty acids - unii:71m78end5s) - omega-3-acid ethyl esters 900 mg - -  omega-3-acid ethyl esters is indicated as an adjunct to diet to reduce triglyceride (tg) levels in adult patients with severe (≥500 mg/dl) hypertriglyceridemia (htg). -   usage considerations: patients should be placed on an appropriate lipid-lowering diet before receiving omega-3-acid ethyl esters and should continue this diet during treatment with omega-3-acid ethyl esters. -  laboratory studies should be done to ascertain that the lipid levels are consistently abnormal before instituting therapy with omega-3-acid ethyl esters. every attempt should be made to control serum lipids with appropriate diet, exercise, weight loss in obese patients, and control of any medical problems such as diabetes mellitus and hypothyroidism that are contributing to the lipid abnormalities. medications known to exacerbate hypertriglyceridemia (such as beta blockers, thiazides, estrogens) should be discontinued or changed if possible prior to consideration of triglyceride-lowering drug therapy. -  

United States - English - NLM (National Library of Medicine)

northstar rx llc - omega-3-acid ethyl esters (unii: d87ygh4z0q) (omega-3 fatty acids - unii:71m78end5s) - omega-3-acid ethyl esters 1 g - omega-3-acid ethyl esters capsules are indicated as an adjunct to diet to reduce triglyceride (tg) levels in adult patients with severe (greater than or equal to 500 mg per dl) hypertriglyceridemia (htg). usage considerations: patients should be placed on an appropriate lipid-lowering diet before receiving omega-3-acid ethyl esters capsules and should continue this diet during treatment with omega-3-acid ethyl esters capsules. laboratory studies should be done to ascertain that the lipid levels are consistently abnormal before instituting therapy with omega-3-acid ethyl esters capsules. every attempt should be made to control serum lipids with appropriate diet, exercise, weight loss in obese patients, and control of any medical problems such as diabetes mellitus and hypothyroidism that are contributing to the lipid abnormalities. medications known to exacerbate hypertriglyceridemia (such as beta blockers, thiazides, estrogens) should be discontinued or changed if possible prior to consideration of triglyceri